Claritev (CTEV) Piper Sandler 37th Annual Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Piper Sandler 37th Annual Healthcare Conference summary
4 Dec, 2025Business performance and client relationships
Renewed top 10 customers, representing 70% of revenue, reflecting strong client relationships and high NPS scores.
Pipeline has increased 67% over the past year, with half of new opportunities from existing clients.
Renewals are seen as growth opportunities, not just retention, with a focus on expanding within the current client base.
Major customer renewals achieved at commensurate economics, supporting continued investment in R&D.
Shifted from focusing on contract renewals to emphasizing a diversified and growing pipeline.
Revenue model and market dynamics
Core revenue model is PSAV (percentage of savings achieved), generating 88% of revenue, with subscription-based revenue as a smaller component.
Identified potential savings typically in the mid to high 20% range of medical charges processed.
Out-of-network claims management is ROI-based, with payment tied to value delivered.
Customers outsource claims management due to the scale, technology, and R&D investment required for effective cost containment.
Identified $25 billion in savings last year, highlighting the scale and impact of services.
Growth drivers and market trends
Commercial health plan medical charges processed grew 7% in 2024 and 8.5% year-to-date in 2025, driven by healthcare inflation and higher mix of high-cost claims.
Growth is concentrated in ambulatory surgery, musculoskeletal, and behavioral health categories.
Out-of-network spend expected to remain stable at 5%-7% of overall healthcare spend over the next three to five years.
Launched six new market verticals this year, expanding addressable market.
Increased focus on transparency, waste, fraud, and abuse in healthcare is driving demand for services.
Latest events from Claritev
- Record bookings, robust AI-driven growth, and disciplined investment fuel expansion.CTEV
Status update6 Mar 2026 - Revenue and EBITDA grew, losses narrowed, and 2026 outlook includes buybacks and expansion.CTEV
Q4 202523 Feb 2026 - Q2 2024 net loss was $576.7M on $233.5M revenue, driven by a $553.7M impairment.CTEV
Q2 20242 Feb 2026 - Q3 2024 net loss surged on a $361.6M impairment as revenue fell 5.1% year-over-year.CTEV
Q3 202416 Jan 2026 - Transformation, tech investment, and data-driven strategy fuel growth and innovation in healthcare.CTEV
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - 2024 revenue declined 3.2% and net loss spiked on impairment as transformation accelerates.CTEV
Q4 202423 Dec 2025 - Healthcare cost management firm files to offer up to $400M in securities for growth and operations.CTEV
Registration Filing16 Dec 2025 - Q3 2025 delivered 6.7% revenue growth, higher margins, and raised guidance on strong renewals.CTEV
Q3 202516 Dec 2025 - Six new market segments and Oracle partnership drive growth and international expansion.CTEV
BofA Securities Leveraged Finance Conference 20253 Dec 2025